Clinical Trials for Rifampin

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCPHI1255
09/28/2013
Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of PF-02341066, a C-MET/HGFR Selective Tyrosine Kinase Inhibitor, Administered Orally to Patients with Advanced Cancer

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.